| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |